Publications

  1. Hay ID, Lee RA, Kaggal S, Morris JC, Stan MN, Castro MR, Fatourechi V, Thompson GB, Charboneau JW, Reading CC. Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid Microcarcinoma. J Endocr Soc. 2020 Nov 1; 4 (11):bvaa135 Epub 2020 Sept 15
    View PubMed
  2. Genere N, Hurtado MD, Cortes T, Athimulam S, Al Ward R, Callstrom MR, Stan MN, Morris JC, Brito JP. DRIVERS OF THE DECISION TO BIOPSY AND FOLLOW-UP OF SMALL SUSPICIOUS THYROID NODULES. Endocr Pract. 2020 May 14 [Epub ahead of print]
    View PubMed
  3. Stan MN, Castro MR. NONSURGICAL TREATMENT OF THYROID CYSTS - "SEAL THEM UP". Endocr Pract. 2020 May; 26 (5):573-575
    View PubMed
  4. Stan MN, Kahaly GJ, Stan MN, Frommer L, Gergely P, Colin L, Amer A, Schuhmann I, Espie P, Rush JS, Basson C, He Y. A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism-A Proof-of-Concept Trial. J Clin Endocrinol Metab. 2020 Mar 1; 105 (3)
    View PubMed
  5. Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Iniguez-Ariza NM, Montori VM, Stan MN. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study. Thyroid. 2020 Mar; 30 (3):357-364 Epub 2020 Feb 26
    View PubMed
  6. Gonzales KM, Stan MN, Morris JC 3rd, Bernet V, Castro MR. The Levothyroxine Absorption Test: A Four-Year Experience (2015-2018) at The Mayo Clinic. Thyroid. 2019 Dec; 29 (12):1734-1742 Epub 2019 Dec 04
    View PubMed
  7. Kahaly GJ, Stan MN, Frommer L, Gergely P, Colin L, Amer A, Schuhmann I, Espie P, Rush JS, Basson C, He YL. A Novel Anti-Cd40 Monoclonal Antibody, Iscalimab, for Control of Graves' Hyperthyroidism - A Proof-Of-Concept Trial. J Clin Endocrinol Metab. 2019 Sep 12 Epub 2019 Sept 12
    View PubMed
  8. Sharma A, Stan MN. Thyrotoxicosis: Diagnosis and Management. Mayo Clin Proc. 2019 Jun; 94 (6):1048-1064 Epub 2019 Mar 25
    View PubMed
  9. Kotwal A, Turcu AF, Sonawane V, Bahn RS, Pittelkow MR, Bridges A, Stan MN. Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case Series. Thyroid. 2019 May; 29 (5):692-699 Epub 2019 Apr 08
    View PubMed
  10. Maraka S, Mwangi R, Yao X, Sangaralingham LR, Singh Ospina NM, O'Keeffe DT, Rodriguez-Gutierrez R, Stan MN, Brito JP, Montori VM, McCoy RG. Variation in treatment practices for subclinical hypothyroidism in pregnancy: US national assessment. J Clin Endocrinol Metab. 2019 Apr 24 [Epub ahead of print]
    View PubMed
  11. Genere N, Stan MN. Current and Emerging Treatment Strategies for Graves' Orbitopathy. Drugs. 2019 Feb; 79 (2):109-124
    View PubMed
  12. Akkus Z, Boonrod A, Siddiquee MR, Philbrick KA, Stan MN, Castro RM, Erickson D, Callstrom MR, Erickson BJ. Reduction of unnecessary thyroid biopsies using deep learning Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2019; 10949:109490W
  13. Kotwal A, Stan M. Current and Future Treatments for Graves' Disease and Graves' Ophthalmopathy. Horm Metab Res. 2018 Dec; 50 (12):871-886 Epub 2018 Oct 04
    View PubMed
  14. Kotwal A, Clark J, Lyden M, McKenzie T, Thompson G, Stan MN. Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience. J Endocr Soc. 2018 Nov 1; 2 (11):1226-1235 Epub 2018 Sept 06
    View PubMed
  15. Iniguez-Ariza NM, Lee RA, Singh-Ospina NM, Stan MN, Castro MR. Ethanol Ablation for the Treatment of Cystic and Predominantly Cystic Thyroid Nodules. Mayo Clin Proc. 2018 Aug; 93 (8):1009-1017 Epub 2018 July 04
    View PubMed
  16. Hamidi O, Callstrom MR, Lee RA, Dean D, Castro MR, Morris JC, Stan MN. Outcomes of Radiofrequency Ablation Therapy for Large Benign Thyroid Nodules: A Mayo Clinic Case Series. Mayo Clin Proc. 2018 Aug; 93 (8):1018-1025 Epub 2018 Mar 21
    View PubMed
  17. Farhadfar N, Stan MN, Shah P, Sonawane V, Hefazi MT, Murthy HS, Zou F, Sican X, Hashmi SK. Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes. Bone Marrow Transplant. 2018 Aug; 53 (8):977-982 Epub 2018 Feb 06
    View PubMed
  18. Kotwal A, Stan M. Thyrotropin Receptor Antibodies-An Overview. Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug; 34 (4S Suppl 1):S20-S27
    View PubMed
  19. Maraka ,, Dean ,, Fatourechi ,, Castro ,, Bahn ,, Thapa ,, Stan ,. Prevention of Overt Hypothyroidism following Radioactive Iodine Therapy for Graves' Disease by Early Initiation of Levothyroxine Therapy 87th Annual Meeting of the American Thyroid Association. 2018.
  20. El-Harasis MA, DeSimone CV, Stan MN, McLeod CJ, Noseworthy PA. Graves' disease-induced complete heart block and asystole. HeartRhythm Case Rep. 2018 Mar; 4 (3):105-108 Epub 2017 Dec 29
    View PubMed
  21. Iniguez-Ariza NM, Stan MN, Bible KC. Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer. Endocrine. 2018 Jan; 59 (1):228-229 Epub 2017 Nov 01
    View PubMed
  22. Sundaresh V, Brito JP, Thapa P, Bahn RS, Stan MN. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study. Thyroid. 2017 Apr; 27 (4):497-505 Epub 2017 Feb 06
    View PubMed
  23. Stan MN, Sonawane V, Sebo TJ, Thapa P, Bahn RS. Riedel's thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf). 2017 Mar; 86 (3):425-430 Epub 2016 Oct 07
    View PubMed
  24. Stan MN, Salvi M. MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials. Eur J Endocrinol. 2017 Feb; 176: (2)R101-R109.
    View PubMed
  25. Maraka S, Mwangi R, McCoy RG, Yao X, Sangaralingham LR, Singh Ospina NM, O'Keeffe DT, De Ycaza AE, Rodriguez-Gutierrez R, Coddington CC 3rd, Stan MN, Brito JP, Montori VM. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017 Jan 25; 356:i6865
    View PubMed
  26. Espinosa De Ycaza AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris JC, Stan MN. Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study. Thyroid. 2016 Nov; 26 (11):1598-1604 Epub 2016 Oct 05
    View PubMed
  27. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct; 26 (10):1343-1421
    View PubMed
  28. Sharma A, Jasim S, Reading CC, Ristow KM, Villasboas Bisneto JC, Habermann TM, Fatourechi V, Stan M. Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study. Thyroid. 2016 Aug; 26 (8):1061-7 Epub 2016 July 06
    View PubMed
  29. Maraka S, Singh Ospina NM, O'Keeffe DT, Rodriguez-Gutierrez R, Espinosa De Ycaza AE, Wi CI, Juhn YJ, Coddington CC 3rd, Montori VM, Stan MN. Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism. Thyroid. 2016 Jul; 26 (7):980-6 Epub 2016 May 16
    View PubMed
  30. Maraka S, Ospina NM, O'Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ, Coddington CC 3rd, Stan MN, Murad MH, Montori VM. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016 Apr; 26 (4):580-90 Epub 2016 Mar 03
    View PubMed
  31. Brito JP, Castaneda-Guarderas A, Gionfriddo MR, Ospina NS, Maraka S, Dean DS, Castro MR, Fatourechi V, Gharib H, Stan MN, Branda ME, Bahn RS, Montori VM. Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease. Thyroid. 2015 Nov; 25 (11):1191-8 Epub 2015 Oct 15
    View PubMed
  32. Shah M, Bancos I, Thompson GB, Richards ML, Kasperbauer JL, Clarke BL, Drake MT, Stan MN. Teriparatide Therapy and Reduced Postoperative Hospitalization for Postsurgical Hypoparathyroidism. JAMA Otolaryngol Head Neck Surg. 2015 Sep; 141: (9)822-7.
    View PubMed
  33. Stan MN, Haglind EG, Drake MT. Early Hypoparathyroidism Reversibility with Treatment of Riedel's Thyroiditis. Thyroid. 2015 Sep; 25: (9)1055-9.
    View PubMed
  34. Brito JP, Castro MR, Dean DS, Fatourechi V, Stan M. Survey of current approaches to non-diagnostic fine-needle aspiration from solid thyroid nodules. Endocrine. 2015 Aug; 49 (3):745-51 Epub 2015 Feb 04
    View PubMed
  35. Stan MN, Garrity JA, Carranza Leon BG, Prabin T, Bradley EA, Bahn RS. Randomized controlled trial of rituximab in patients with Graves' orbitopathy. J Clin Endocrinol Metab. 2015 Feb; 100 (2):432-41 Epub 2014 Oct 24
    View PubMed
  36. Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, Callstrom M, Elraiyah TA, Prokop LJ, Stan MN, Murad MH, Morris JC, Montori VM. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Apr; 99 (4):1253-63 Epub 2013 Nov 25
    View PubMed
  37. Stan MN, Sathananthan M, Warnes CA, Brennan MD, Thapa P, Bahn RS. Amiodarone-induced thyrotoxicosis in adults with congenital heart disease--clinical presentation and response to therapy. Endocr Pract. 2014 Jan; 20: (1)33-40.
    View PubMed
  38. Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, Murad MH, Bahn RS. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2013 Sep; 98 (9):3671-7 Epub 2013 July 03
    View PubMed
  39. Stan MN, Ammash NM, Warnes CA, Brennan MD, Thapa P, Nannenga MR, Bahn RS. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study. Int J Cardiol. 2013 Aug 10; 167(3):821-6. Epub 2012 Mar 02.
    View PubMed
  40. Adhikari LJ, Sciallis AP, Reynolds J, Jenkins S, Smith C, Stan MN, Nassar A. Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies. Thyroid. 2013 Aug; 23: (8)982-8.
    View PubMed
  41. Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment. Thyroid. 2013 May; 23 (5):620-5
    View PubMed
  42. Bancos I, Grant CS, Nadeem S, Stan MN, Reading CC, Sebo TJ, Algeciras-Schimnich A, Singh RJ, Dean DS. Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract. 2012 Jul-Aug; 18: (4)441-9.
    View PubMed
  43. Stan MN, Garrity JA, Bahn RS. The evaluation and treatment of graves ophthalmopathy. Med Clin North Am. 2012 Mar; 96 (2):311-28 Epub 2012 Feb 22
    View PubMed
  44. Widmer RJ, Erickson D, Stan MN, McKusick MA, Garovic VD. Multiple causes for secondary hypertension in a young female. Nephology Reviews. 2012; 4(1).
  45. Stan MN, Hess EP, Bahn RS, Warnes CA, Ammash NM, Brennan MD, Thapa P, Montori VM. A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease. J Thyroid Res. 2012; 2012:210529 Epub 2012 Feb 12
    View PubMed
  46. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association, American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011 Jun; 21(6):593-646. Epub 2011 Apr 21.
    View PubMed
  47. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol. 2011 Jun; 46 (3):155-63 Epub 2011 Apr 12
    View PubMed
  48. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association//American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011 May-Jun; 17 (3):456-520
    View PubMed
  49. Stan MN, Bahn RS. Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid. 2010 Jul; 20 (7):777-83
    View PubMed
  50. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D, Sosa JA, Stan MN. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 2009 Jul; 19(7):673-4.
    View PubMed
  51. Espiritu RP, Stan MN. Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancer. Endocr Pract. 2008 Nov; 14(8):1023-6.
    View PubMed
  52. Stan MN, Garrity JA, Bradley EA, Woog JJ, Bahn MM, Brennan MD, Bryant SC, Achenbach SJ, Bahn RS. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy. J Clin Endocrinol Metab. 2006 Dec; 91(12):4817-24. Epub 2006 Sep 19.
    View PubMed
  53. Stan M, Morris JC. Thyrotropin-axis adaptation in aging and chronic disease. Endocrinol Metab Clin North Am. 2005 Dec; 34(4):973-92, x.
    View PubMed